Skip to Main Content

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is noticeably modest this time around. We plan to hang with a couple of our short people, stroll around with Mrs. Pharmalot, and catch up on our reading. And what about you? Summer is near, so this may be a good time to plan a needed getaway. You could also enjoy the great outdoors now. Perhaps you have an urge to forage for unneeded items at a garage sale. Or you could tally how much more you will have to spend on avocados and tequila because you-know-who is frothing over a certain border issue. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon. …

As a closely watched meeting of cancer researchers gets under way in Chicago on Friday — call it Woodstock for oncologists — a new analysis finds that more cancer therapies have been launched recently than ever before, an unprecedented amount of clinical development is underway, and the spending is rising at double-digit rates, STAT says. Last year saw a record 15 new oncology treatments launched for 17 tumor types, the pipeline of drugs in late-stage development expanded by 19% in 2018, and the mean cost for the new medications last year exceeded $175,500.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!